Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Were Hedge Funds Right About Flocking Into Descartes Systems Group (DSGX) ?

Before we spend countless hours researching a company, we’d like to analyze what insiders, hedge funds and billionaire investors think of the stock first. We would like to do so because our research has shown that the elite investors’ consensus returns have been exceptional. In the following paragraphs, we find out what the billionaire investors and hedge funds think of Descartes Systems Group (NASDAQ:DSGX).

Descartes Systems Group (NASDAQ:DSGX) investors should pay attention to an increase in support from the world’s most elite money managers lately. DSGX was in 12 hedge funds’ portfolios at the end of the fourth quarter of 2018. There were 9 hedge funds in our database with DSGX holdings at the end of the previous quarter. Our calculations also showed that DSGX isn’t among the 30 most popular stocks among hedge funds.

Hedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ large-cap stock picks indeed failed to beat the market between 1999 and 2016. However, we were able to identify in advance a select group of hedge fund holdings that outperformed the market by 32 percentage points since May 2014 through March 12, 2019 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that’ll significantly underperform the market. We have been tracking and sharing the list of these stocks since February 2017 and they lost 27.5% through March 12, 2019. That’s why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to.

Michael Platt BlueCrest Capital

Let’s review the key hedge fund action surrounding Descartes Systems Group (NASDAQ:DSGX).

Hedge fund activity in Descartes Systems Group (NASDAQ:DSGX)

At the end of the fourth quarter, a total of 12 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 33% from the previous quarter. The graph below displays the number of hedge funds with bullish position in DSGX over the last 14 quarters. So, let’s check out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

DSGX_apr2019

Among these funds, Renaissance Technologies held the most valuable stake in Descartes Systems Group (NASDAQ:DSGX), which was worth $18.3 million at the end of the third quarter. On the second spot was Echo Street Capital Management which amassed $15 million worth of shares. Moreover, Arrowstreet Capital, Diker Management, and Tiger Legatus Capital were also bullish on Descartes Systems Group (NASDAQ:DSGX), allocating a large percentage of their portfolios to this stock.

Now, some big names were breaking ground themselves. Diker Management, managed by Mark N. Diker, created the most outsized position in Descartes Systems Group (NASDAQ:DSGX). Diker Management had $4.6 million invested in the company at the end of the quarter. Chuck Royce’s Royce & Associates also made a $4.1 million investment in the stock during the quarter. The other funds with new positions in the stock are Israel Englander’s Millennium Management, Ken Griffin’s Citadel Investment Group, and Michael Platt and William Reeves’s BlueCrest Capital Mgmt..

Let’s also examine hedge fund activity in other stocks – not necessarily in the same industry as Descartes Systems Group (NASDAQ:DSGX) but similarly valued. These stocks are Xencor Inc (NASDAQ:XNCR), Terex Corporation (NYSE:TEX), The Ensign Group, Inc. (NASDAQ:ENSG), and Chart Industries, Inc. (NASDAQ:GTLS). All of these stocks’ market caps resemble DSGX’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
XNCR 13 211098 -2
TEX 13 258200 -8
ENSG 18 62521 5
GTLS 15 264312 -3
Average 14.75 199033 -2

View table here if you experience formatting issues.

As you can see these stocks had an average of 14.75 hedge funds with bullish positions and the average amount invested in these stocks was $199 million. That figure was $66 million in DSGX’s case. The Ensign Group, Inc. (NASDAQ:ENSG) is the most popular stock in this table. On the other hand Xencor Inc (NASDAQ:XNCR) is the least popular one with only 13 bullish hedge fund positions. Compared to these stocks Descartes Systems Group (NASDAQ:DSGX) is even less popular than XNCR. Hedge funds clearly dropped the ball on DSGX as the stock delivered strong returns, though hedge funds’ consensus picks still generated respectable returns. Our calculations showed that top 15 most popular stocks) among hedge funds returned 24.2% through April 22nd and outperformed the S&P 500 ETF (SPY) by more than 7 percentage points. A small number of hedge funds were also right about betting on DSGX as the stock returned 44.2% and outperformed the market by an even larger margin.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...